TILs ex vivo Expansion for Research Purposes
At Vivia Biotech, we specialize in producing TILs from diverse solid tumor indications, offering complete clinical information, comprehensive immunophenotyping, and potency assays conducted on cell lines

At Vivia Biotech, we specialize in producing TILs from diverse solid tumor indications, offering complete clinical information, comprehensive immunophenotyping, and potency assays conducted on cell lines.
  • Access to real patient solid tumor samples with relevant clinical data
  • Non-GMP production and expansion of TILs
  • Research into their behavior and therapeutic applications of your drug candidates for custom in vitro experimentation with target tumor cells
  • Unlock TILs’ potential with full immunophenotypic characterization:
    • At baseline and at the end of expansion
    • T Cell subsets, exhaustion, and senescence markers, together with immune check point inhibitors
    • HLA-typing
  • TILs collection across various solid tumor indications
  • RNAseq analysis available
  • Directly shipped at your facilities, or
  • Functional assays @Vivia with your compounds
ImgTILsExVivoExpansionForResearchPurposes
  • Access to real patient solid tumor samples with relevant clinical data
  • Non-GMP production and expansion of TILs
  • Research into their behavior and therapeutic applications of your drug candidates for custom in vitro experimentation with target tumor cells
  • Unlock TILs’ potential with full immunophenotypic characterization:
    • At baseline and at the end of expansion
    • T Cell subsets, exhaustion, and senescence markers, together with immune check point inhibitors
    • HLA-typing
  • TILs collection across various solid tumor indications
  • RNAseq analysis available
ImgTILsExVivoExpansionForResearchPurposes
  • Directly shipped at your facilities, or
  • Functional assays @Vivia with your compounds
  • Access to real patient solid tumor samples with relevant clinical data
  • Non-GMP production and expansion of TILs
  • Research into their behavior and therapeutic applications of your drug candidates for custom in vitro experimentation with target tumor cells
  • Unlock TILs’ potential with full immunophenotypic characterization:
    • At baseline and at the end of expansion
    • T Cell subsets, exhaustion, and senescence markers, together with immune check point inhibitors
    • HLA-typing
  • TILs collection across various solid tumor indications
  • RNAseq analysis available
ImgTILsExVivoExpansionForResearchPurposes
  • Directly shipped at your facilities, or
  • Functional assays @Vivia with your compounds
  • If you are attending the AACR Annual Meeting in San Diego this April, we would be delighted to discuss our capabilities further
Click Here